Abstract. Injury to articular cartilage is often associated with an inflammatory reaction and frequently results in the development of post-traumatic osteoarthritis (post-traumatic OA). Cell death, inflammation and loss of proteoglycans participate in these mechanisms with p38MAPK being one of the pivotal signaling kinases. Therefore, the interaction of trauma and of the pro-inflammatory cytokine IL-1β was investigated in an in vitro tissue model of human osteoarthritic cartilage. Trauma was induced by impacting cartilage explants with a drop-tower system and its effect was measured in terms of cell survival, gene expression and the release of mediators. In addition, the effect of concomitant IL-1β stimulation and p38MAPK inhibition by SB203580 was investigated. We found a significant decrease in chondrocyte viability after trauma, but no additional effect of IL-1β stimulation. SB203580 had a tendency to improve cell survival suggesting a role for p38 signaling in cell viability after impact in an inflammatory environment. We showed that various mediators are released in response to trauma with or without IL-1β stimulation, differing in composition and time response. Trauma resulted in an increased release of IL-6, whereas TNF-α and IL-1β release was unaffected. Prostaglandin (PG) and NO synthesis pathways were both affected by trauma and/ or IL-1β. We demonstrate for the first time an elevated release of prostaglandin D2 (PGD2) by human articular cartilage in response to a single mechanical impact. The up-regulation of mediators was time-dependent, with a more early increase of PGD2 compared to prostaglandin E2 (PGE2) and a late induction of NO by co-stimulation with IL-1β between 6 and 24 h.
Introduction
Traumatic joint damage is a known risk factor for the subsequent development of post-traumatic osteoarthritis (post-traumatic OA) and is most commonly accompanied by macroscopic lesions of the articular surface (1) . Impact loads at energies insufficient to grossly disrupt the articular surface can result in post-traumatic OA as well (2) . Frequently, joint traumas also include an injury of the adjacent soft tissues like the synovium or ligaments which lead to a significant increase of the pro-inflammatory cytokines, IL-1β and TNF-α, in the synovial fluid with a peak of cytokine levels within 24 h of trauma (3) . Based on these findings, a concerted action of trauma-induced and cytokine-induced processes in cartilage is expected to be responsible for the development of posttraumatic OA.
The underlying mechanisms are complex and only partially understood. The substantial increase in chondrocyte death after joint trauma is believed to play a pivotal role in post-traumatic OA pathogenesis. Mechanical stress generates necrosis (4) and induces apoptosis (5) involving the release of reactive oxygen species (ROS) (6) . Furthermore, an impact results in the early loss of glycosaminoglycans due to mechanical disruption of the cartilage extracellular matrix and a subsequent induction of degrading enzymes supporting cartilage degradation (7, 8) .
The increase of pro-inflammatory cytokines after joint injury (3) also supports the progression of post-traumatic OA. Mediators like IL-1β are potent activators of cartilage degradation by decreasing matrix production and increasing the production of catabolic enzymes and inflammatory mediators (9, 10) . Interactions of traumagenic and inflammation-derived effects are described. Mechanical injury potentiates the catabolic effects of TNF-α and IL-1α causing an increased degradation of proteoglycans in cartilage (11, 12) .
New therapeutic approaches try to address the underlying pathogenetic mechanisms in post-traumatic OA in order to surpass the effectiveness of surgical restoration and of the removal of intraarticular blood. Efforts to reduce chondrocyte death or dysfunction after joint injury may be a useful strategy to delay or prevent the onset of post-traumatic OA (2) . For example, treatment of injured cartilage with the membrane-stabilizing surfactant P188 has been shown to prevent chondrocytes from undergoing early necrosis (4) as well as subsequent apoptosis in adjacent regions (13) . A reduction of trauma-induced apoptosis in vitro has also been observed after treatment with caspase inhibitors or substances that reduce the amount of ROS (5, 6, 14, 15) . In addition to the prevention of chondrocyte death by ROS diminishment, the reduction of inflammatory and degradative processes in cartilage seems to attenuate the development of post-traumatic OA, while the inhibition of cyclooxygenase could lower the trauma-induced release of prostaglandin E2 (PGE2) and could reduce apoptosis (16) . The inhibition of matrix metalloproteinases was shown to reduce the loss of glycosaminoglycans following in vitro cartilage injury (7) .
These findings implicate the involvement of many different processes in the initiation of post-traumatic OA. We, therefore, hypothesized that inhibition of a central signaling pathway mediating trauma-induced and inflammation-induced effects could positively affect several processes and thus be an advantageous therapeutic approach. One of the relevant signaling pathways is that of MAPK (mitogen-activated protein kinase), especially the p38MAPK pathway, as it plays a pivotal role in the inflammatory processes in joint destruction. Inhibition of the p38MAPK by the inhibitor SB203580 was previously shown to reduce PGE2 and NO-release of chondrocytes in an in vitro inflammation model (17) and demonstrated an attenuation of cartilage degradation in vivo (18) . Furthermore, p38MAPK is thought to be a key player in mechanical stressinduced signaling as activation of p38MAPK by mechanical stress was observed in bovine cartilage and human chondrocytes (19, 20) . Inhibition of p38 activation after cartilage injury is also responsible for the chondroprotective effects of the P188 surfactant (13) .
We, therefore, investigated the interaction of trauma and of pro-inflammatory cytokines in an in vitro tissue model of human osteoarthritic cartilage concerning cell survival, gene expression and release of mediators. Inhibition with the p38MAPK inhibitor, SB203580, was investigated as a possible therapeutic approach.
Materials and methods
Cartilage explants. Human osteoarthritic cartilage was obtained from donors undergoing total knee joint replacement due to OA. Informed consent was obtained from all the patients according to the terms of the Ethics Committee of the university of ulm. Overall, tissue samples from 32 patients were included in the study. The mean age of the donors was 66 years (range 53-82 years). Only tissue regions of the femoral condyles were used that had a macroscopically smooth surface and no severe osteoarthritic changes.
Full-thickness cartilage explants, 6 mm in diameter, were harvested by punching the cartilage with a biopsy punch and separating the cartilage from the underlying subchondral bone with a scalpel. Each explant was weighed and cultivated in complete medium consisting of 1:1 DMEM/Ham's F12 supplemented with 10% fetal bovine serum, 0.5% penicillin/ streptomycin (PAA Laboratories, Pasching, Austria), 0.5% L-glutamine and 10 µg/ml 2-phospho-L-ascorbic acid trisodium salt (Sigma-Aldrich, Fluka, Seelze, Germany) for 24 h in an incubator (37˚C, 21% O 2 , 95% humidity). Afterwards, the explants were cultivated up to 15 days in serum-free medium consisting of DMEM supplemented with 1% sodium pyruvate, 0.5% L-glutamine, 1% non-essential amino acids, 0.5% penicillin/streptomycin and 0.1% serum effective substitute (SES-1 Solution A). SES-1 Solution B was freshly added to the medium in each case. All chemicals were purchased from Biochrom (Berlin, Germany) unless specified otherwise.
Impact loading.
A specially designed drop-tower ( Fig. 1 ) was used to impart loads to an indenter, a flat-faced steel rod of 15 mm in diameter, resting on the explant surface. Two levels of impact energy were applied by dropping a 600 g mass from a height of 10 cm and 20 cm on the indenter, which resulted in an impact energy of 0.59 J and 1.18 J, respectively. The dropping mass, held in place by a height-adjustable cotter pin, that was released manually, was removed from the indenter immediately after impact. unloaded explants served as controls.
In addition to the impact loading, some of the cartilage explants were also treated with IL-1β (10 ng/ml) (PeproTech, Hamburg, Germany) and/or with SB203580 (1 µM) (gift of Ratiopharm, ulm, Germany). Twenty-four hours after the described treatments the cartilage explants and the culture media were harvested.
mRNA isolation and cDNA synthesis. For total RNA isolation the cartilage explants were frozen in liquid N 2 . After pulverization with a microdismembrator (Sartorius BBI Systems, Melsungen, Germany), RNA was isolated using the Lipid Tissue Mini kit (Qiagen, Hilden, Germany). RNA was reverse transcribed with the Omniscript RT kit (Qiagen) and used for (3) was placed on the cartilage explant (1), lying on a loading platen (2). The dropping mass (4) was held in place by a height-adjustable cotter pin (5) . By manual release of the cotter pin the mass fell down and transferred the drop energy to the indentor.
quantitative real-time PCR-analysis (ABIPrism 7000 system; Applied Biosystems, Darmstadt, Germany).
Real-time polymerase chain reaction (RT-PCR).
Relative gene expression analysis (2 -∆∆Ct method) using the Platinum ELISA and NO assays. Absolute concentrations of nitrite, a stable end-product of the NO metabolism, were determined in the media of the tissue culture using the Griess assay (Griess Reagent System; Promega, Mannheim, Germany) according to the manufacturer's instructions. PGE2 production was measured in the media by the PGE2 ELISA Correlate EIA™ kit (Biotrend, Assay Designs, Cologne, Germany).
PGD2 production was measured with the prostaglandin D2 EIA kit (Cayman, Biomol, Hamburg, Germany) and IL-6, IL-1β and TNF-α production was measured by the human Quantikine ELISA kits for IL-6, IL-1β/IL-1F2 and TNF-α, respectively (all R&D Systems, Wiesbaden, Germany), according to the manufacturer's instructions.
Cytotoxicity assay. A Live/Dead
® viability/cytotoxity assay (Molecular Probes, Invitrogen) was performed to determine the percentage of viable cells, which was carried out by staining the chondrocytes of an unfixed tissue section (0.5 mm thickness) with 1 µM Calcein AM and 2 µM ethidium homodimer-1 for 30 min. After washing in PBS, the tissue sections were microscopically analyzed with the help of a z-stack module (AxioVision software; Carl zeiss, Jena, Germany).
Statistical analysis. For standardization of the gene expression levels determined by real-time PCR-analysis, the mRNA expression was normalized to that of 18SrRNA. Differential regulation was determined by calculating the ratios of gene expression under different treatments. The data represent the means ± SEM. A two-tailed paired t-test was used to evaluate significant differences in the means.
Results
In vitro trauma model. To establish a reliable in vitro trauma model, different energies were used for cartilage impact and the percentage of vital cells was subsequently determined (Fig. 2A) . To preserve enough vital cells, the lower impact energy of 0.59 J was chosen for further experiments.
Detection of pro-inflammatory cytokines. using ELISAs, we determined the release of IL-1β, IL-6 and TNF-α after trauma and the release of IL-6 and TNF-α after trauma plus IL-1β stimulation by the cartilage explants of at least 4 donors. Fig. 3A and C show significant elevations of IL-6 and TNF-α release. IL-1β release was not affected by trauma (data not shown). Control stimulation of unimpacted cartilage explants with IL-1β (n≥4) revealed 6-fold and 15-fold increases in IL-6 and TNF-α release, respectively (data not shown). Furthermore, we could detect a time-dependent release of IL-6 (Fig. 3B) .
Influence of trauma, pro-inflammatory stimulation and additional p38MAPK inhibition on cell viability. Impacted explants were cultivated with or without IL-1β for up to 15 days and processed for Live/Dead staining (Fig. 2B) . Quantitative analysis revealed a reduction of vital cells from 65 to 35% 24 h after trauma but no further enhancement of trauma-induced cell death by IL-1β within 15 days of cultivation post-trauma. As a significant effect of trauma on cell viability was already observed after 24 h, this time point was chosen for further analyses of gene expression and mediator release. 
A B C
To address the question for the involvement of the p38MAPK signaling pathway in this context, we investigated the effect of SB203580 on cell viability in impacted cartilage explants with or without IL-1β stimulation after 24 h (Fig. 2C) .
Though not significant, SB203580 could increase the mean number of viable cells from 36% to 48% in impacted, stimulated explants. Neither IL-1β stimulation nor treatment with SB203580 alone influenced cell viability, as determined in a control experiment (data not shown).
Influence of trauma, pro-inflammatory stimulation and p38MAPK inhibition on cell metabolism. Quantitative analysis of the prostaglandin synthesis pathway revealed significant effects of trauma as well as trauma combined with IL-1β stimulation, whereas p38MAPK inhibition acted differentially, as shown in Fig. 4 . The release of PGE2 correlated with the gene expression of the corresponding enzymes, COX2 and PTGES (Fig. 4A-C) . The production of PGD2 was elevated by the different treatments (Fig. 4E) whereas the A B C Figure 4 . Effects of trauma, IL-1β stimulation and p38MAPK inhibition on the prostaglandin synthesis pathway. Cartilage explants were traumatized (0.59 J) and stimulated or not with IL-1β (10 ng/ml). SB203580 (1 µM) was used for p38MAPK inhibition. Cartilage explants without treatments served as control. mRNA expression level of PTGDS was not significantly altered (data not shown). In a control experiment (n≥2), IL-1β stimulation of unimpacted explants caused a 112-fold and 22-fold up-regulation of COX2 and PTGES gene expression, accompanied by a 16-fold and 5-fold increase in PGE2 and PGD2 release, respectively (data not shown). The effect of the impact combined with the IL-1β stimulation on PGE2 synthesis exceeded the trauma effect, whereas both treatments had a comparable effect on PGD2 release. COX2 induction was significantly higher after concomitant trauma and IL-1β stimulation compared to trauma alone, but in the same range as COX2-induction by IL-1β alone. ultimately, IL-1β amplified the trauma-induced effect on COX2 gene expression and PGE2 release. The time course of PGE2 and PGD2 release is shown in Fig. 4D and F, indicating different time responses of the two prostaglandins. The effects of impact, impact combined with IL-1β stimulation and additional p38MAPK inhibition on the NO synthesis pathway are shown in Fig5. IL-1β stimulation of unimpacted explants (n=9) revealed a 220-fold up-regulation of NOS2A and a 10-fold increase in NO production (data not shown). The time course of NO release (Fig. 5C ) revealed a late induction compared to the prostaglandins.
A B C D E F

mRNA-expression of (A) COX2 [n≥13, n(TS)=5, n(TILS)=7] and (B) PTGES [n≥10, n(TS/TILS)=3] after 24 h was determined by real-time PCR. Expression levels are normalized to 18SrRNA and shown relative to control. (C) Release of PGE2 relative to control after 24 h (n≥7). (D) Time-dependent release of PGE2 (n=5). (E) Release of PGD2 relative to control after 24 h (n≥5). (F) Time-dependent release of PGD2 (n=3
To address the trauma and inflammatory effects on further mediators involved in cell death, the release of Fas ligand (FasL) was investigated (data not shown). No detectable release of FasL was found by any of the analyzed cartilage explants.
Discussion
This study investigated the combined effects of cartilage trauma and IL-1β stimulation as well as the involvement of the p38MAPK signaling pathway on the cell viability in human osteoarthritic cartilage explants. Twenty-four hours post trauma, a significant reduction (30%) of viable cells was observed, which is comparable to other human trauma models (16, 21) . An additional stimulation with IL-1β did not enhance cell death in our tissue culture model. Though IL-1 was described to synergistically enhance proteoglycan degradation in mechanically injured cartilage (11), we could find no additive effect of IL-1β on cell loss. In order to elucidate the involved mediators and their relation to the observed chondrocyte death, we investigated the synthesis pathways of PGE2, PGD2 and NO as well as the secretion of IL-6, TNF-α, IL-1β and FasL. In summary, an induction of PGD2, PGE2 and IL-6 could be observed by trauma 24 h post-impact whereas concomitant IL-1β stimulation led to elevated levels of PGE2, IL-6, NO, TNF-α and PGD2, with levels of the latter subsiding by 24 h. Keeping in mind the reduced amount of viable cells after trauma, there is an additive effect detectable in the release of IL-6 and PGE2 after trauma in combination with IL-1β stimulation compared to an individual treatment by impact or IL-1β stimulation, respectively.
An impact-induced IL-6 up-regulation in healthy human ankle cartilage has been described by Bajaj et al (13) , indicating an unequivocal trauma-effect in articular cartilage with and without slight pre-existing damage and implicating IL-6 as a possible mediator of cell death. The additive IL-6 induction by IL-1β in impacted explants in our study, however, caused no additional cell loss. Sui et al described an amplifying effect of IL-6 in a bovine cartilage injury model concerning proteoglycan catabolism (12) . But IL-6 seems not to be responsible for cell death, which was also described for another cartilage injury model (22) .
In accordance to another study (16) , the analysis of the PGE2 synthesis pathway in impacted explants showed a significant up-regulation of COX2 and PTGES gene expression as well as of PGE2 release 24 h post-trauma, accompanied by an increase in cell death. Cartilage injury with concomitant IL-1β stimulation resulted in a significantly stronger COX2-induction and tended to increase the PGE2 release compared to trauma alone. This elevation was not reflected in an enhanced cell death, indicating a secondary role of PGE2 in cell death signaling, as previously described (23) .
For the first time, we could describe an increased PGD2 release after single mechanical impact of human articular cartilage. This finding correlates to effects observed in sheared chondrocytes in cell culture (23) , indicating a general effect of mechanical stimulation in chondrocytes which is preserved in the context of cartilage matrix. Trauma as well as trauma plus IL-1β stimulation resulted in a comparable PGD2 induction which is in agreement with the observed comparable levels of cell death under both conditions, supporting a major role of PGD2 in chondrocyte death (23) . In contrast to the elevated PGD2 level, PTGDS gene expression was not altered 24 h post-impact with or without IL-1β stimulation, which could be explained by an early peak of PTGDS-expression which was fading away by 24 h. Though we found no additional IL-1β-mediated PGD2 induction, zayed et al described IL-1β to induce PTGDS-expression in cell culture after 12-24 h (24). These findings indicate that trauma may be responsible for the early PGD2-induction in our model and that traumainduced PGD2 possibly prevents a subsequent IL-1β-induced up-regulation of PTGDS gene expression, to some extent by a negative feedback mechanism (24) . There was no significant induction of NO release by trauma, though NOS2A gene expression was slightly elevated after impact. Fermor et al, however, showed that specific conditions of compression increase NOS2A expression and NO production in porcine cartilage explants (25) . The discrepancies between their study and our results could be due to differences in the conditions of mechanical stimulation or in the species used. Furthermore, the level of NO production in osteoarthritic cartilage could be elevated per se resulting in a lower effect of additional mechanical stress, as the NO-induction by OA-relevant cytokines like IL-1β or TNF-α was found to be substantially stronger than that by mechanical stress (25) . The strong IL-1β-effect on NOS2A gene expression and NO production in cartilage indicates that most of the NO release is probably induced by inflammatory processes of the injured tissue (cartilage and adjacent tissue) rather than by primary mechanical stress. Although NO has been reported to be a key inducer of apoptosis in chondrocytes, we could find no correlation of NO release and cell death in our study, possibly due to the late induction of NO. Furthermore, the explicit role of NO in cell death and apoptosis is still a matter of discussion (26) .
The difference in the mediator composition caused by additional IL-1β stimulation of impacted cartilage explants was not reflected in differences in cell viability, however, differential effects of a p38MAPK inhibition could be detected. We observed that SB203580 tended to reduce cell death in impacted and IL-1β-stimulated explants. The protective trend was accompanied by a further elevation of IL-6 and NO levels, whereas the PGD2 level was not altered. The increased levels of IL-6 released under IL-1β stimulation may have protective effects, as IL-6 plays a major role in tendon reparative processes (27) . IL-6 is able to activate the Jak/STAT3 pathway implicated in cell proliferation and survival (28) .
In contrast, p38MAPK inhibition could not increase the number of viable cells in impacted explants without IL-1β stimulation, but resulted in a reduced IL-6 and an increased PGD2 release. The latter effect might be explained by a possible COX1-dependent PGD2 synthesis, primarily described in macrophages (29) and a COX1 induction through mechanical loading, observed in osteoblasts (30) . Assuming comparable mechanisms in chondrocytes, an imbalance in the arachidonic acid cascade by p38 inhibition could result in enhanced metabolism via COX1 and a subsequent increased PGD2 release. As PGD2 is considered to play a role in chondrocyte apoptosis (23), SB203580-induced PGD2 increase may reduce cell viability and level out other protective effects of the inhibitor. A comparable effect of p38MAPK inhibition was also described for mechanically-induced apoptosis of intervertebral disc chondrocytes (31) .
An explanation for the different effects of p38MAPK inhibition with and without concomitant IL-1β stimulation can only be assumed. Trauma as well as IL-1β may induce destructive and protective processes via diverse signaling pathways. The balance of these processes may be displaced in different directions by the inhibition of an involved pathway.
In contrast to our findings, other studies described a significant reduction of injury-related chondrocyte death by p38 inhibition in cartilage trauma models without concomitant IL-1β stimulation (13, 19) . The discrepancies may be due to differences in the experimental designs. One study (19) applied the p38 inhibitor 90 min prior impaction in order to abolish immediate p38 signaling and both studies used an inhibitor concentration higher than that in our study (10 and 20-fold, respectively) , that might result in inhibition of additional kinases, such as JNK (32) . We opted to apply the inhibitor post-trauma in order to remain within a possible therapeutic time frame and selected an inhibitor concentration that could ensure specificity. The question of optimal selective and effective inhibitor concentrations under tissue culture conditions remains open. Furthermore, the use of human osteoarthritic cartilage in our study may account for speciesand age-dependent differences or may reflect OA-associated changes of the cartilage such as bio-distribution and/or preexisting synthesis of prostaglandins and other mediators.
In addition, not only negative but also protective signals could be mediated by p38, and could be abolished by p38 inhibition. Our results clearly indicate that one has to be aware of the highly complex interactions of the different players activating and modulating signaling pathways.
In summary, we showed that a single impact induces an increased PGD2 release and other trauma-typical effects in human early-stage osteoarthritic cartilage explants, showing that aged osteoarthritic chondrocytes are still susceptible for mechanical injury. The pro-inflammatory cytokine IL-1β had no additive effect on trauma-induced cell loss in contrast to the described synergistic effect of IL-1 and trauma on proteoglycan loss in cartilage (11) . A cocktail of mediators was induced by trauma alone and by trauma with IL-1β stimulation, differing in composition and time-response. In tendency, p38MAPK inhibition diminished trauma-induced chondrocyte death in an inflammatory environment, suggesting a role for p38MAPK signaling in cell viability after impact, as described by others (13, 19) .
